Calidad de vida según función visual en degeneración macular húmeda asociada a la edad tratada con Bevacizumab / Quality of Life According to Visual Function in Age-related Wet Macular Degeneration Treated with Bevacizumab

Introducción: La degeneración macular asociada a la edad, es causa frecuente de ceguera o baja visión en el adulto mayor. La valoración de la calidad de vida relativa a la función visual, es fundamental en estos pacientes tratados con Bevacizumab. Objetivo: Evaluar la calidad de vida en relación con la función visual en pacientes con degeneración macular tratada con Bevacizumab asociada a la edad. Métodos: Estudio descriptivo longitudinal prospectivo realizado en el ICO "Ramón Pando Ferrer", desde enero de 2019 hasta mayo de 2021. La muestra fue de 52 pacientes. El cuestionario NEI VFQ-25 fue aplicado antes y después de la administración de las tres dosis del medicamento intravítreo. Resultados: Predominó el sexo femenino, el grupo etario de mayor representación fue el de 60 a 79 años, la enfermedad sistémica más frecuente fue la hipertensión y ocular, la catarata. Casi todos los pacientes ganaron más de dos líneas en la cartilla de Snellen, el 42,3 por ciento presentó una ganancia de 3 líneas o más. El resultado de la mayoría de los elementos que explora el test, así como la función visual total es significativo desde el punto de vista estadístico. Conclusiones: Hubo una mejoría en la calidad de vida relativa a la función visual en los pacientes después de ser tratados con Bevacizumab. No existió una relación directamente proporcional entre la mejor agudeza visual post tratamiento y la mejora de la función visual total(AU)

Introduction: Age-related macular degeneration constitutes a frequent cause of blindness or low vision in the older adult. The assessment of quality of life related to visual function is essential in these patients treated with Bevacizumab. Objective: To assess the quality of life in relation to visual function in patients with age-related macular degeneration treated with Bevacizumab, at the ICO "Ramón Pando Ferrer", from January 2019 to May 2021. Methods: Prospective longitudinal descriptive study. The sample was 52 patients and the NEI VFQ-25 questionnaire was applied before and after three doses of the intravitreal drug. Results: Female gender predominated, the most represented age group was 60 to 79 years, the most frequent systemic disease was hypertension and the most frequent ocular disease was cataract. Almost all patients gained more than two lines in the Snellen chart, 42.3 percent presented a gain of 3 lines or more. The result of most of the items explored by the test, as well as the total visual function is statistically significant. Conclusions: There was an improvement in quality of life relative to visual function in patients after being treated with Bevacizumab. There was no directly proportional relationship between improved post-treatment visual acuity and improvement in total visual function(AU)

NEI-VFQ-25 questionnaire used in corneal transplantation outcome analysis / 国际眼科杂志(Guoji Yanke Zazhi)

@#Corneal disease is a common disease that causes blindness, and keratoplasty is the main method for the treatment of corneal blindness. Visual function examination alone cannot fully evaluate the impact of surgery on patients, while the vision-related quality of life scale covers all aspects of visual indicators, which can more comprehensively reflect the feelings of patients. In recent years, it has gradually become a common method to evaluate the therapeutic effect of keratoplasty. This paper briefly reviews the research progress of NEI-VFQ-25 scale in corneal transplantation in recent years.

Calidad de vida según la escala NEI VFQ-25 en la cirugía facorrefractiva de pacientes hipermétropes présbitas / Quality of life according to the NEI VFQ-25 scale in presbyopic hyperopic patients undergoing phaco-refractive surgery

Objetivos: Describir la calidad de vida relativa a la función visual en pacientes hipermétropes présbitas después de la extracción del cristalino con fines refractivos, así como las características sociodemográficas y los resultados refractivos pre y poscirugía. Métodos: se realizó un estudio descriptivo, longitudinal y prospectivo a 70 pacientes hipermétropes présbitas, operados en el período de enero a diciembre del año 2016, a quienes se les aplicó el cuestionario NEI VFQ-25, por primera vez usado en Cuba, y que permitió conocer la respuesta clínica y el grado de satisfacción del paciente. Resultados: la edad promedio fue de 54,67 años; predominó el sexo femenino y la piel blanca. Hubo una mejoría evidente de la visión y de la calidad de vida mostrada en los resultados de todos los elementos explorados en la prueba realizada, los cuales fueron mejores en el posoperatorio. Fue un estudio clínico y estadísticamente significativo. Conclusiones: los pacientes hipermétropes présbitas, operados de lensectomía refractiva, mejoran clínica y estadísticamente su calidad visual y su calidad de vida relativa a la función visual. La prueba de calidad de vida relativa a la función visual utilizada permite evaluar ambos parámetros(AU)

Objectives: crystalline lens surgery has become refractive surgery. The present study is aimed at describing vision-related quality of life in presbyopic hyperopic patients after crystalline lens removal for refractive purposes, as well as the sociodemographic characteristics and refractive outcomes before and after surgery. Methods: a prospective longitudinal descriptive study was conducted of 70 presbyopic hyperopic patients undergoing surgery from January to December 2016, who were given the questionnaire NEI VFQ-25, used for the first time in Cuba, to obtain information about clinical response and degree of patient satisfaction. Results: mean age was 54.67 years; female sex and white skin prevailed. Results show obvious improvement in both vision and vision-related quality of life, made evident by the results of tests conducted in the postoperative period. The study was clinically and statistically significant. Conclusions: presbyopic hyperopic patients undergoing refractive lensectomy experience clinical and statistical improvement of their vision and vision-related quality of life. The vision-related quality of life test used allows evaluation of both parameters(AU)

Escala NEI VFQ-25 como instrumento de medición de la calidad de vida relativa a la visión / NEI VFG-25 scale as a measuring instrument of the vision-related quality of life

La salud es un elemento decisivo de la calidad de vida. El concepto de calidad de vida es cada vez más utilizado como medida del bienestar y depende de elementos objetivos y de la valoración subjetiva que el paciente hace de diferentes aspectos de su vida. Las pruebas de calidad de vida son adaptables al campo de la Oftalmología y aplicables a cualquier paciente, además de las pruebas de función visual. El NEI VFQ-25 mide las dimensiones del estado de salud orientado a la visión. El uso de estos estudios permite conocer la respuesta clínica y el grado de satisfacción del paciente, lo que conlleva una mejor calidad de vida. Con la presente investigación se pretende mostrar una de las pruebas más utilizadas para describir los resultados de la calidad visual(AU)

The health is a decisive element of the life quality. The quality of life concept is more and more utilized, it depends on objective elements, and subjective opinion of the patient makes of different aspects of its life. The quality of life test is adaptive to the ophthalmology patient, beside the tests of visual function. The NEI VFQ-25, measures the dimensions from the health to the vision. The use of these studies allows knowing the clinical response and the patient satisfaction, what means a better life quality(AU)

Changes in Optical Quality of Cataract Patients' Corrected Visual Acuity before and after Phacoemulsification

PURPOSE: To evaluate objectively the improvement level of a patient's visual function using the NEI-VFQ-25 questionnaire pre- and post-operatively and the OQAS results from the patient group who had the same corrected visual acuity pre- and post-operatively. METHODS: We examined and compared the NEI-VFQ-25 test, OSI, MTF cut-off, strehl ratio, OQAS, and width at 50% and 10% in 24 eyes of 24 patients who had cataract surgery between December 2011 and February 2012. The patients' corrected visual acuity in both eyes had no change (0.8 and 0.8) pre-operatively and 2 months post-operatively (1.0 and 1.0). RESULTS: The satisfaction level regarding the patients' visual function increased. The NEI-VFQ-25 test was 71.54 +/- 14.88 points pre-operatively and 85.70 +/- 6.17 points post-operatively. OSI decreased to 3.13 +/- 1.66 (OSI value) and 1.53 +/- 0.58 (OSI value), and MTF cut off value improved from 14.51 +/- 6.97 (C/deg) to 27.63 +/- 8.98 (C/deg). Strehl ratio was improved to 0.09 +/- 0.03 and 0.14 +/- 0.03, width at 50% improved to 8.44 +/- 3.73 and 4.52 +/- 1.90 and width at 10% improved to 35.30 +/- 15.22 and 18.04 +/- 8.87 pre- and post-operatively, respectively. CONCLUSIONS: The NEI-VFQ-25 test reflected the vision improvement in patients where after cataract surgery, determination of the visual function improvement only through vision would not be possible. In addition, the OQAS showed the quality of vision improved through quantified values.

A Validation and Reliability Study of the Korean Version of National Eye Institute Visual Function Questionnaire 25

PURPOSE: To translate and evaluate the reliability and validity of the Korean version of the National Eye Institute Visual Functioning Questionnaire-25 (NEI-VFQ-25). METHODS: Two bilingual ophthalmologists independently translated the original English version of the NEI-VFQ-25 into written Korean. A panel of the Korean Retina Society reviewed the translations to form a single reconciled forward translation of the Korean version of the NEI-VFQ-25. Another ophthalmologist back-translated this first draft into English. Both the first draft and back-translated draft were edited by a professional translator. To evaluate the correlation and validity, results between the original NEI-VFQ-25 and the Korean version, completed by the bilingual participants, were compared. RESULTS: The Korean version of the National Eye Institute Visual Functioning Questionnaire-25 was developed by translation, back-translation, and expert supervision. Results from 23 bilingual participants between the original NEI-VFQ-25 and the Korean version were compared and showed statistically significant correlation, with a Spearman's correlation coefficient of 0.4 or greater. The Kolmogorov-Smirnov test results showed no statistically significant differences between the two questionnaires. CONCLUSIONS: Translation and validation of the Korean version of the NEI-VFQ-25 was achieved.

Assessment of Functional Vision Score and Vision-Specific Quality of Life in Individuals With Retinitis Pigmentosa

PURPOSE: To determine the relationship between the American Medical Association's (AMA) functional vision score (FVS) and vision-specific quality of life in retinitis pigmentosa (RP) patients using the National Eye Institute's Visual Functioning Questionnaire (NEI-VFQ 25). METHODS: One hundred eight patients with RP participated in the study. We measured best-corrected visual acuity, conducted Goldmann perimetry, and collected the self-reported NEI-VFQ 25. The FVS was calculated using the functional field score (FFS) and the functional acuity score (FAS). The correlations of the VFQ composite scores to the FVS, FFS, and FAS were determined using correlation and regression analyses. RESULTS: FVS was highly correlated to the BCVA (r=0.69, p<0.001), the FFS (r=0.86, p<0.001) and the FAS (r=0.73, p<0.001). Significant correlations of the VFQ composite score to the BCVA (r=0.60, p<0.001), FFS (r=0.44, p<0.001), FAS (r=0.60, p<0.001), FVS (r=0.58, p<0.001) were also found. However, the correlation strengths of BCVA, FVS, FAS, and FFS to NEI-FVQ were not different. CONCLUSIONS: In RP patients, the vision-specific quality of life was correlated with the AMA guidelines' FVS, FFS, and FAS. Their correlation degrees to NEI-FVQ were not different. This result suggests that vision-specific quality of life can be explained by both visual acuity and visual field in RP patients.